Efficacy and Safety of Roflumilast in Korean Patients with COPD

PURPOSE: Roflumilast is the only oral phosphodiesterase 4 inhibitor approved to treat chronic obstructive pulmonary disease (COPD) patients [post-bronchodilator forced expiratory volume in 1 second (FEV(1)) <50% predicted] with chronic bronchitis and a history of frequent exacerbations. This stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Yonsei Med J
Autors principals: Lee, Jae Seung, Hong, Yoon Ki, Park, Tae Sun, Lee, Sei Won, Oh, Yeon-Mok, Lee, Sang-Do
Format: Artigo
Idioma:Inglês
Publicat: Yonsei University College of Medicine 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4951470/
https://ncbi.nlm.nih.gov/pubmed/27189287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.4.928
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars